The FDA announced on Tuesday the termination of all pediatric clinical trials of Amgen's thyroid drug Sensipar following the death of a 14-year-old patient. Officials said they are still gathering information surrounding the teen's death and they remain uncertain if the drug played a role in the death.

Full Story:
Reuters, CBS News

Related Summaries